PMVK

Phosphomevalonate kinase (PMVK) plays a critical role in the mevalonate pathway, which is essential for cholesterol biosynthesis. This enzyme catalyzes the phosphorylation of mevalonate-5-phosphate to mevalonate-5-diphosphate, a key step in the production of isoprenoids. These molecules are vital for various cellular functions, including membrane integrity and hormone synthesis. Dysregulation of PMVK activity, such as through overexpression or mutations, can alter cholesterol homeostasis, potentially leading to disorders like hypercholesterolemia and contributing to cardiovascular diseases. In research and clinical settings, PMVK activity is often evaluated to understand its role in cholesterol metabolism and its broader implications in metabolic disorders. Scientists utilize genetic perturbations and chemical inhibitors to modulate PMVK function, exploring potential therapeutic avenues for conditions associated with cholesterol imbalance. Measuring PMVK levels and activity can offer insights into disease mechanisms and serve as a biomarker for assessing cardiovascular risk. By targeting PMVK, researchers aim to develop strategies that could modulate cholesterol levels more effectively, providing a therapeutic benefit in managing cardiovascular health.